CD4 and lymphoma: Since we observed a significant skewing of the CD8+:CD4+ T-cell ratio during reconstitution, we separately analyzed the impact of the metabolic profile of CD8+ and CD4+ T-cells on the clinical outcome of lymphoma patients.